Valeant Pharmaceuticals (NYSE: VRX), a specialty pharmaceutical company, saw its shares sink by 11.8% last month, according to S&P Global Market Intelligence.What went wrong? The drugmaker's shares retreated largely in response to its weaker-than-expected fourth-quarter and full-year earnings release that hit the wires toward the end of the month. Image source: Getty Images.Continue reading
Why Valeant Pharmaceuticals International Stock Sank In February
newsfeedback@fool.com (George Budwell), The Motley Fool
Tue, 03/13/2018 - 5:00am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more